Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

Journal: Nature

Published: 2020-07-24

DOI: 10.1038/s41586-020-2577-1

Affiliations: 23

Authors: 45

Go to article
Institutions Share
Infectious and Inflammatory Disease Center, SBP, United States of America (USA) 0.27
Department of Microbiology, ISMMS, United States of America (USA) 0.10
California Institute for Biomedical Research (Calibr), Scripps Research, United States of America (USA) 0.09
Global Health and Emerging Pathogens Institute, ISMMS, United States of America (USA) 0.08
Li Ka Shing Faculty of Medicine, HKU, China 0.06
Department of Medicine, UC San Diego, United States of America (USA) 0.04
Carol Yu Centre for Infection, HKU, China 0.04
State Key Laboratory of Emerging Infectious Diseases, HKU, China 0.04
NIH NCI Center for Cancer Research (CCR), United States of America (USA) 0.03
Department of Biological Sciences, Purdue University, United States of America (USA) 0.03
Department of Biochemistry, Purdue University, United States of America (USA) 0.03
Center of Integrative Bioinformatics Vienna (CIBIV), Max Perutz Labs Vienna, Austria 0.02
Department of Integrative Structural and Computational Biology (ISCB), Scripps Research, United States of America (USA) 0.02
UCLA Department of Molecular and Medical Pharmacology (DMMP), United States of America (USA) 0.02
Department of Cell, Developmental and Regenerative Biology, ISMMS, United States of America (USA) 0.02
Black Family Stem Cell Institute (BFSCI), ISMMS, United States of America (USA) 0.02
Texas Biomedical Research Institute (Texas Biomed), United States of America (USA) 0.02
Inception Therapeutics, United States of America (USA) 0.02
Graduate School of Biomedical Sciences, ISMMS, United States of America (USA) 0.01
College of Computer, Mathematical, and Natural Sciences (CMNS), UMCP, United States of America (USA) 0.01
Division of Infectious Diseases, ISMMS, United States of America (USA) 0.01
Tisch Cancer Institute (TCI), ISMMS, United States of America (USA) 0.01

Return